These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9821232)

  • 21. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of diroton on characteristics of 24-hours arterial pressure monitoring in hypertensive patients with polycythemia vera].
    Gorokhovskaia GN; Zav'ialova AI; Martynov AI
    Ter Arkh; 2003; 75(8):26-32. PubMed ID: 14520846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA; Rizzoni D;
    J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of ramipril on the glucose/insulin coefficient and the ventricular mass index in patients with light to moderate arterial hypertension].
    Germán Cardona-Muñoz E; Noriega-Arellano J; Hernández-Chávez A; López-Alvarado A; González-Ortiz M; Martínez-Abundis E; Delgado Hurtado JM; Ramos-Remus C; Gamez-Nava I; Ayub-Ayala M
    Arch Cardiol Mex; 2003; 73(1):24-30. PubMed ID: 12820491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension.
    Mistry GC; Maes AL; Lasseter KC; Davies MJ; Gottesdiener KM; Wagner JA; Herman GA
    J Clin Pharmacol; 2008 May; 48(5):592-8. PubMed ID: 18353996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of mild and moderate hypertension with enalapril (multicenter study of enap and enap N in Ukraine)].
    Dziak GV; Kolomiets SN; Minakov AI; Fushteĭ IM; Iavorskiĭ OG; Bekker VF; Vankhanen VN; Davydova IV; Zaĭtseva VI; Kolesnik TV; Kolomiets VV; Svishchenko EP; Taran AI; Shlykova NA; Barbich-Zhagar B
    Ter Arkh; 1999; 71(1):31-4. PubMed ID: 10097297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
    Pasini AF; Garbin U; Nava MC; Stranieri C; Pellegrini M; Boccioletti V; Luchetta ML; Fabrizzi P; Lo Cascio V; Cominacini L
    Am J Hypertens; 2007 Apr; 20(4):443-50. PubMed ID: 17386354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of captopril-enalapril replacement therapy in hypertensive patients under ambulatory blood pressure monitoring].
    Ruszty L; Hidas I; Iványi J; Dudás M; Molnár S
    Orv Hetil; 1996 Dec; 137(51):2851-4. PubMed ID: 9679620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of acute and long-term administration of ramipril on circadian rhythm of blood pressure in essential hypertension.
    Cavazzini D; Amadei G; Manfredini R; Musacci G; Mele D; Longhini C
    Adv Ther; 1995; 12(1):11-21. PubMed ID: 10150320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical experience with converting-enzyme inhibitors in hypertension.
    Weber MA
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):45-51. PubMed ID: 3037889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension.
    Mallion JM; Dutrey-Dupagne C; Vaur L; Genes N; Renault M; Elkik F; Baguet P; Boutelant S
    J Hypertens; 1996 Jan; 14(1):137-44. PubMed ID: 12013487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Co-renitek treatment of patients with moderate and severe forms of hypertensive disease].
    Chazova IE; Ratova LG; Dmitriev VV; Khanbalaeva MN; Kotkina TI
    Ter Arkh; 2003; 75(8):21-6. PubMed ID: 14520845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A comparison of the effect of Capoten (captopril) and ramipril on the circadian profile of the arterial pressure and peripheral hemodynamics in patients with hypertension combined with diabetes mellitus].
    Filatova EV; Vikhert OA; Rogoza AN; Arabidze GG; Kukharchuk VV
    Ter Arkh; 1996; 68(5):67-70. PubMed ID: 9082606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Beneficial effects of Hartil on cardiovascular remodeling process in elderly and old patients with isolated systolic arterial hypertension].
    Kiphshidze N; Zubiashvili T; Chagunava K
    Georgian Med News; 2008 Jan; (154):7-13. PubMed ID: 18323584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antihypertensive efficacy, tolerance and safety of lisinopril (sinopril) and captopril (capoten) in patients with mild and moderate arterial hypertension].
    Ol'binskaia LI; Sizova ZhM; Zheleznykh EA; Fitilev SB; Sergeeva TE; Pukhlianko ME; Potapova GN
    Ter Arkh; 1999; 71(11):61-4. PubMed ID: 10626341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Ramipril and Isradipin on hemorheological profiles in patients with arterial hypertension.
    Muravyov AV; Zaitsev LG; Muravyov AA; Yakusevich VV; Sirotkina AM
    Clin Hemorheol Microcirc; 1998 Jul; 18(2-3):185-90. PubMed ID: 9699040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.